| Literature DB >> 34752497 |
Gilar Gorji-Bahri1, Niloofar Moradtabrizi1, Atieh Hashemi1.
Abstract
Accurate and reliable relative gene expression analysis via the Reverse Transcription-quantitative Real Time PCR (RT-qPCR) method strongly depends on employing several stable reference genes as normalizers. Utilization of the reference genes without analyzing their expression stability under each experimental condition causes RT-qPCR analysis error as well as false output. Similar to cancerous tissues, cancer cell lines also exhibit various gene expression profiles. It is crucial to recognize stable reference genes for well-known cancer cell lines to minimize RT-qPCR analysis error. In this study, we showed the expression level and investigated the expression stability of eight common reference genes that are ACTB, YWHAZ, HPRT1, RNA18S, TBP, GAPDH, UBC, and B2M, in two sets of cancerous cell lines. One set contains MCF7, SKBR3, and MDA-MB231 as breast cancer cell lines. Another set includes three hepatic cancer cell lines, including Huh7, HepG2, and PLC-PRF5. Three excel-based softwares comprising geNorm, BestKeeper, and NormFinder, and an online tool, namely RefFinder were used for stability analysis. Although all four algorithms did not show the same stability ranking of nominee genes, the overall results showed B2M and ACTB as the least stable reference genes for the studied breast cancer cell lines. While TBP had the lowest expression stability in the three hepatic cancer cell lines. Moreover, YWHAZ, UBC, and GAPDH showed the highest stability in breast cancer cell lines. Besides that, a panel of five nominees, including ACTB, HPRT1, UBC, YWHAZ, and B2M showed higher stability than others in hepatic cancer cell lines. We believe that our results would help researchers to find and to select the best combination of the reference genes for their own experiments involving the studied breast and hepatic cancer cell lines. To further analyze the reference genes stability for each experimental condition, we suggest researchers to consider the provided stability ranking emphasizing the unstable reference genes.Entities:
Mesh:
Year: 2021 PMID: 34752497 PMCID: PMC8577734 DOI: 10.1371/journal.pone.0259669
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Properties of the designed primers of the eight nominee reference genes.
| Gene | Accession number | Mean PCR efficiency ± SD | Evidences |
|---|---|---|---|
|
| NM_002046.6 | 1.903 ± 0.026 | [ |
|
|
| 1.913 ± 0.009 | [ |
|
| NM_021009 | 1.908 ± 0.023 | [ |
|
| NM_003406 | 1.903 ± 0.019 | [ |
|
| NM_001101.5 | 1.917 ± 0.022 | [ |
|
| NR_003286 | 1.935 ± 0.025 | [ |
|
| NM_003194 | 1.908 ± 0.022 | [ |
|
| NM_000194.3 | 2 ± 0.024 | [ |
The Mean PCR efficiency ± SD refers to the average of PCR efficiencies of each reference gene across all six cell lines and all biological and technical replicates.
Fig 1Expression of reference genes and Cq distribution in hepatic and breast cancer cell lines.
A. Integrity analysis of the isolated RNA derived from SKBR3 cell line. The 2:1 ratio of RNA28S/RNA18S band intensities on 1% agarose gel confirmed the integrity of the extracted RNA. Similar results were obtained for the other five cancer cell lines. B. Specificity analysis of the designed primers. Based on the results obtained from agarose gel electrophoresis, a single band of each gene’s RT-qPCR product at the anticipated size confirmed the specificity of the used primers. The isolated RNA sample (Fig 1A), cDNA template, and the RT-qPCR products (Fig 1B) belonged to the SKBR3 cell line. Full-length gels are presented in S1 Fig. C. Cq values distribution of the nominee reference genes in three hepatic cancer cell lines, three breast cancer cell lines, and their combination. The graph is provided as box and whiskers that the latter shows 10–90 percentile.
The Cq values of nominee reference genes in hepatic and breast cancer cell lines.
| Genes | Combined | Hepatic | Breast | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Cq Min | Cq Max | Mean Cq ± SD | Cq Min | Cq Max | Mean Cq ± SD | Cq Min | Cq Max | Mean Cq ± SD | |
|
| 15.63 | 21.14 | 17.96 ± 1.834 | 17.23 | 21.14 | 18.90 ± 1.447 | 15.63 | 20.6 | 17.03 ± 1.796 |
|
| 16.77 | 22.09 | 19.43 ±1.704 | 16.77 | 22.09 | 19.42 ± 1.712 | 17.21 | 21.89 | 19.44 ± 1.86 |
|
| 16.61 | 23.08 | 19.08 ±1.936 | 16.61 | 23.08 | 19.26 ± 2.4 | 17.67 | 22 | 18.91 ± 1.553 |
|
| 18.34 | 23.38 | 20.45 ±1.787 | 18.71 | 23.09 | 21.06 ± 1.699 | 18.34 | 23.38 | 19.84 ± 1.801 |
|
| 19.58 | 30.1 | 22.82 ± 3.044 | 20.49 | 26.15 | 23 ± 1.93 | 19.58 | 30.1 | 22.63 ± 4.072 |
|
| 10.3 | 16.15 | 12.63 ± 1.574 | 11.5 | 14.29 | 12.7 ± 1.209 | 10.3 | 16.15 | 12.55 ± 1.994 |
|
| 22.39 | 32 | 26.81 ± 3.649 | 25.09 | 32 | 29 ± 2.59 | 22.39 | 31.3 | 24.61 ± 3.321 |
|
| 24.29 | 29.75 | 26.12 ± 1.647 | 24.74 | 29.75 | 26.89 ± 1.687 | 24.29 | 27.89 | 25.36 ± 1.311 |
The Mean Cq ± SD values in the combined column refer to the statistical analysis of samples of six cancer cell lines and their biological replicates (n = 12). Accordingly, the hepatic column and breast column contain Mean Cq values derived from samples of three hepatic cancer cell lines (including two biological replicates for each cell line, n = 6) and three breast cancer cell lines (including two biological replicates for each cell line, n = 6), respectively. The Cq Min and Cq Max values in hepatic and breast columns represent the lowest and the highest Cq values across samples of three different hepatic or three different breast cancer cell lines and their biological replicates, respectively. Each of these Cq Min or Cq Max values is itself the mean of technical triplicates.
Fig 2Stability ranking orders of the studied reference genes resulted from A. geNorm, B. NormFinder, and C. RefFinder algorithms in the combined sample besides the hepatic and breast cancer cell lines separately. D. Indication of the optimum number of reference genes in the combined sample besides the breast and hepatic cancer cell lines separately via geNorm algorithm. The combined sample refers to hepatic and breast cancer cells together.
Stability ranking order of nominee reference genes determined by GeNorm algorithm.
| Combined | Hepatic | Breast | |||
|---|---|---|---|---|---|
| Ranking Order | Average Expression Stability (M) | Ranking Order | Average Expression Stability (M) | Ranking Order | Average Expression Stability (M) |
|
| 0.59 |
| 0.477 |
| 0.222 |
|
| 0.59 |
| 0.477 |
| 0.222 |
|
| 0.735 |
| 0.526 |
| 0.307 |
|
| 0.918 |
| 0.646 |
| 0.465 |
|
| 1.008 |
| 0.763 |
| 0.591 |
|
| 1.198 |
| 0.847 |
| 0.968 |
|
| 1.472 |
| 1.044 |
| 1.257 |
|
| 1.760 |
| 1.26 |
| 1.628 |
Stability ranking order of nominee reference genes determined by NormFinder algorithm.
| Combined | Hepatic | Breast | |||
|---|---|---|---|---|---|
| Ranking Order | Stability Value | Ranking Order | Stability Value | Ranking Order | Stability Value |
|
| 0.055 |
| 0.047 |
| 0.042 |
|
| 0.115 |
| 0.068 |
| 0.046 |
|
| 0.122 |
| 0.072 |
| 0.047 |
|
| 0.133 |
| 0.095 |
| 0.103 |
|
| 0.136 |
| 0.099 |
| 0.173 |
|
| 0.159 |
| 0.11 |
| 0.206 |
|
| 0.192 |
| 0.124 |
| 0.356 |
|
| 0.197 |
| 0.284 |
| 0.468 |
Stability ranking order of nominee reference genes determined by BestKeeper algorithm.
| Hepatic | Breast | ||
|---|---|---|---|
| Ranking Order | SD ± CP | Ranking Order | SD ± CP |
|
| 0.98 |
| 0.85 |
|
| 1.11 |
| 1.03 |
|
| 1.11 |
| 1.18 |
|
| 1.11 |
| 1.19 |
|
| 1.31 |
| 1.34 |
|
| 1.43 |
| 1.44 |
|
| 1.89 |
| 2.23 |
|
| 2.05 |
| 3.07 |
Stability ranking order of nominee reference genes determined by RefFinder algorithm.
| Combined | Hepatic | Breast | |||
|---|---|---|---|---|---|
| Ranking Order | Geomean of Ranking | Ranking Order | Geomean of Ranking | Ranking Order | Geomean of Ranking |
|
| 1.68 |
| 2 |
| 1.57 |
|
| 1.86 |
| 2.28 |
| 1.68 |
|
| 2.83 |
| 3.13 |
| 2.71 |
|
| 3 |
| 3.16 |
| 2.99 |
|
| 4.56 |
| 3.5 |
| 4.73 |
|
| 5 |
| 3.83 |
| 6.24 |
|
| 7 |
| 7 |
| 6.74 |
|
| 8 |
| 8 |
| 8 |